Mason AL, et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. Gastroenterology 2014;147. 1338-1349 e5;quiz e15.
·237 P a1.Clinicalfeaturesand of 5.CrosignaniA,BattezzatiM,InvernizziPet managementprimary JGastroenterol 13-3327 2008;1 biliarycirrhosis【J】,World 4(21):33 6.Beuers andsitesofactionof acidin U.Druginsight:Mechanisms ursodeoxycholiccholestasis, NatC1in 1 PractGastroenterol 8328 2006;2(6)I:3...
COMBINATION drug therapyTREATMENT effectivenessQUALITY of lifeENDOSCOPIC gastrointestinal surgeryMESALAMINEThe authors concluded that the combination therapy is superior to mesalazine monotherapy, using the Mayo score and the Inflammatory Bowel Disease Questionnaire (IBDQ) to assess the clinical ...
However, the functional molecular/cellular mechanisms of UDCA‐mediated protective effect against estrogen‐induced cholestasis remains unclear and is the focus of this study.doi:10.1096/fasebj.30.1_supplement.1119.9Xiaojiaoyang LiJiangsu Key Laboratory of Drug ScreeningChina Pharmaceutical UniversityNanjing...
The article discusses the potential use of ursodeoxycholic acid (UDCA), a drug commonly used to treat liver disease, in the prevention and treatment of COVID-19. The authors conducted a study using administrative databases from Lombardy, Italy to investigate the impact of UDCA treatment on SARS-...
for the site-specific delivery of the drug (28). It is known that aminopeptidase activity increases from the ligament of Treitz to the distal ileum (28-31). Among the host of brush border peptidases, aminopeptidase A, in particular, is able to ...
[粤遭泽贼则葬糟贼] 摇 韵遭躁藻糟贼蚤增藻摇 To study the curative effect of ursodeoxycholic acid used for premature parenteral nutri tion associated cholestasis(PNAC) . 酝藻贼澡燥凿泽摇 源园 premature children with PNAC born in our hospital from June 圆园园愿to December 圆园员员 were ...
Use 24 norudca The present invention relates to an active substance using the___delta e__lambda_kappa_acid and\\/or an acceptable salt and ester of the drug for productio... T Michael,H Alan,F Peter 被引量: 0发表: 2017年 24-nor-UDCA for treatment of autoimmune hepatitis nor-ursodeox...
While development of single drug treatments has been the main strategy in the last decade, the fact that a large proportion of these approaches have failed to meet pre-specified endpoints52 strongly support the notion that treating NASH requires the development of combinatorial approaches. Building ...
In a large study by Tomida et al., risks of biliary pain or gallstone complications (acute cholecystitis) were reduced in both symptomatic and asymptomatic gallstone carriers, although gallstones were generally not dissolved. Also, biliary pancreatitis might be prevented by long-term UDCA treatment....